We are committed to sustainable growth in both talent and products,
and contribute to the health and well-being of humanity through continuous innovation and equitable healthcare access.
Continuously conduct quality system evaluations to enhance compliance depth and strengthen the growth of quality capabilities and culture.
Continuously improve the full lifecycle quality management system, optimize quality management platforms, and advance international quality management practices.
Continuously enhance digital information systems and implement quality talent development programs.
10 production lines have successfully passed GMP compliance inspections conducted by the U.S. FDA, the European Union, and the World Health Organization (WHO).
15 APIs have passed FDA and WHO GMP compliance inspections.
The right first time for drug products exceeds 99%
the pass rate for market sampling inspections is 100%
Zero product recalls due to quality-related issues
Pharmaceutical subsidiaries comply 100% with GMP standards
Quality training has been delivered to 100% of our employees
The average annual quality training for operation personnel is 93 hours per year per person
*As of December 31, 2024